- Home
- SRPT vs EVT Comparison
SRPT vs EVT Comparison
Compare SRPT & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- EVT
- Stock Information
- Founded
- SRPT 1980
- EVT 2003
- Country
- SRPT United States
- EVT United States
- Employees
- SRPT N/A
- EVT N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- EVT Finance Companies
- Sector
- SRPT Health Care
- EVT Finance
- Exchange
- SRPT Nasdaq
- EVT Nasdaq
- Market Cap
- SRPT 2.0B
- EVT 1.7B
- IPO Year
- SRPT 1997
- EVT N/A
- Fundamental
- Price
- SRPT $18.46
- EVT $24.36
- Analyst Decision
- SRPT Hold
- EVT
- Analyst Count
- SRPT 30
- EVT 0
- Target Price
- SRPT $44.37
- EVT N/A
- AVG Volume (30 Days)
- SRPT 9.6M
- EVT 115.5K
- Earning Date
- SRPT 08-06-2025
- EVT 01-01-0001
- Dividend Yield
- SRPT N/A
- EVT 8.32%
- EPS Growth
- SRPT N/A
- EVT N/A
- EPS
- SRPT N/A
- EVT 6.63
- Revenue
- SRPT $2,481,531,000.00
- EVT $69,404,302.00
- Revenue This Year
- SRPT $9.41
- EVT N/A
- Revenue Next Year
- SRPT N/A
- EVT N/A
- P/E Ratio
- SRPT N/A
- EVT $3.55
- Revenue Growth
- SRPT 64.89
- EVT N/A
- 52 Week Low
- SRPT $10.42
- EVT $19.20
- 52 Week High
- SRPT $138.81
- EVT $25.83
- Technical
- Relative Strength Index (RSI)
- SRPT 48.03
- EVT 58.25
- Support Level
- SRPT $17.95
- EVT $24.07
- Resistance Level
- SRPT $19.61
- EVT $24.57
- Average True Range (ATR)
- SRPT 1.20
- EVT 0.20
- MACD
- SRPT -0.06
- EVT 0.02
- Stochastic Oscillator
- SRPT 19.69
- EVT 67.19
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.